We only have this paper's title and publication details.
Read it at the sourcePhase 2 trial reports participant demographics and baseline characteristics in metastatic solid tumors, indicating critical starting points for treatment response assessment.
Participant demographics and baseline characteristics.
No takes yet. Share an insight, caveat, or question.
Meric‐Bernstam et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: